JP2025511819A5 - - Google Patents

Info

Publication number
JP2025511819A5
JP2025511819A5 JP2024559337A JP2024559337A JP2025511819A5 JP 2025511819 A5 JP2025511819 A5 JP 2025511819A5 JP 2024559337 A JP2024559337 A JP 2024559337A JP 2024559337 A JP2024559337 A JP 2024559337A JP 2025511819 A5 JP2025511819 A5 JP 2025511819A5
Authority
JP
Japan
Prior art keywords
pyrano
dihydro
methylpiperidine
fluoro
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024559337A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511819A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/053561 external-priority patent/WO2023194964A1/en
Publication of JP2025511819A publication Critical patent/JP2025511819A/ja
Publication of JP2025511819A5 publication Critical patent/JP2025511819A5/ja
Pending legal-status Critical Current

Links

JP2024559337A 2022-04-07 2023-04-07 Nlrp3阻害剤としての縮合ピリダジン誘導体 Pending JP2025511819A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263328709P 2022-04-07 2022-04-07
US63/328,709 2022-04-07
PCT/IB2023/053561 WO2023194964A1 (en) 2022-04-07 2023-04-07 Fused pyridazine derivatives as nlrp3 inhibitors

Publications (2)

Publication Number Publication Date
JP2025511819A JP2025511819A (ja) 2025-04-16
JP2025511819A5 true JP2025511819A5 (cg-RX-API-DMAC7.html) 2026-04-13

Family

ID=86329425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024559337A Pending JP2025511819A (ja) 2022-04-07 2023-04-07 Nlrp3阻害剤としての縮合ピリダジン誘導体

Country Status (6)

Country Link
US (1) US20250340563A1 (cg-RX-API-DMAC7.html)
EP (1) EP4504733A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025511819A (cg-RX-API-DMAC7.html)
AR (1) AR129012A1 (cg-RX-API-DMAC7.html)
TW (1) TW202345838A (cg-RX-API-DMAC7.html)
WO (1) WO2023194964A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
CA3226995A1 (en) * 2021-07-21 2023-01-26 Nico Therapeutics, Inc. Annulated pyridazine compound
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
TW202545527A (zh) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
AR119731A1 (es) * 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
TW202231281A (zh) * 2020-12-25 2022-08-16 大陸商上海拓界生物醫藥科技有限公司 一類含噠嗪的化合物及其醫藥用途
CA3226995A1 (en) * 2021-07-21 2023-01-26 Nico Therapeutics, Inc. Annulated pyridazine compound

Similar Documents

Publication Publication Date Title
JP2021138755A5 (cg-RX-API-DMAC7.html)
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
RU2455288C2 (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2008513515A5 (cg-RX-API-DMAC7.html)
JP2015172062A5 (cg-RX-API-DMAC7.html)
JP2014532640A5 (cg-RX-API-DMAC7.html)
JP2018527336A5 (cg-RX-API-DMAC7.html)
JP2005513026A5 (cg-RX-API-DMAC7.html)
JP2007536224A5 (cg-RX-API-DMAC7.html)
RU2012132692A (ru) Новые ингибиторы s-нитрозоглутатионредуктазы
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
JP2011503032A5 (cg-RX-API-DMAC7.html)
JP2005508349A5 (cg-RX-API-DMAC7.html)
JP2005509024A5 (cg-RX-API-DMAC7.html)
HRP20110335T1 (hr) Supstituirani biciklolaktamski spojevi
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
JP2012515166A5 (cg-RX-API-DMAC7.html)
RU2011147203A (ru) Гетероароматические и ароматические пиперазинилазетидиниламиды в качестве ингибиторов моноацилглицеринлипазы
JP2007504160A5 (cg-RX-API-DMAC7.html)
RU2014121984A (ru) Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
JP2017537948A5 (cg-RX-API-DMAC7.html)
HRP20140346T1 (hr) DERIVATI 1,2,3-TRIAZOLA, NAMIJENJENI UPOTREBI KAO INHIBITORI STEAROIL-CoA-DESATURAZE
JP2023518948A5 (cg-RX-API-DMAC7.html)
HRP20161631T1 (hr) Dihidropirazolni gpr40 modulatori
RU2008135690A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы